{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:16Z","timestamp":1787016916304,"version":"build-2736575974"},"reference-count":23,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,9,4]]},"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Idiopathic nephrotic syndrome is the most common glomerular disease in childhood with an incidence of 1.8 cases per 100 000 children in Germany. The treatment of the first episode implies two aspects: induction of remission and sustainment of remission. The recent Kidney Disease Improving Global Outcomes, American Academy of Pediatrics and German guidelines for the initial treatment of the first episode of a nephrotic syndrome recommend a 12-week course of prednisone. Despite being effective, this treatment is associated with pronounced glucocorticoid-associated toxicity due to high-dose prednisone administration over a prolonged period of time. The aim of the INTENT study (Initial treatment of steroid-sensitive idiopathic nephrotic syndrom in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial) is to show that an alternative treatment regimen with mycophenolic acid is not inferior regarding sustainment of remission, but with lower toxicity compared with treatment with glucocorticoids only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and design<\/jats:title>\n                    <jats:p>The study is designed as an open, randomised, controlled, multicentre trial. 340 children with a first episode of steroid-sensitive nephrotic syndrome and who achieved remission by a standard prednisone regimen will be enrolled in the trial and randomised to one of two treatment arms. The standard care group will be treated with prednisone for a total of 12 weeks; in the experimental group the treatment is switched to mycophenolate mofetil, also for a total of 12 weeks in treatment duration. The primary endpoint is the occurrence of a treated relapse within 24 months after completion of initial treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval for this trial was granted by the ethics committee of the Medical Faculty of the University of Heidelberg (AFmu-554\/2014). The study results will be published in accordance with the Consolidated Standards of Reporting Trials statement and the Standard Protocol Items: Recommendations for Interventional Trials guidelines. Our findings will be submitted to major international paediatric nephrology and general paediatric conferences and submitted for publication in a peer-reviewed, open-access journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>DRKS0006547; EudraCT2014-001991-76; Pre-result.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Date of registration<\/jats:title>\n                    <jats:p>30 October 2014; 24 February 2017.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-024882","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:05:26Z","timestamp":1539216326000},"page":"e024882","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil\n                    <i>versus<\/i>\n                    prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3245-7481","authenticated-orcid":false,"given":"Rasmus","family":"Ehren","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital K\u00f6ln, University Hospital K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus R","family":"Benz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital K\u00f6ln, University Hospital K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg","family":"Doetsch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital K\u00f6ln, University Hospital K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Fichtner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Gellermann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital Berlin, University Hospital Berlin Charit\u00e9, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital Hannover, University Hospital Hannover, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"H\u00f6cker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F","family":"Hoyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital Essen, University Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"K\u00e4stner","sequence":"additional","affiliation":[{"name":"KKS (Coordination Center for Clinical Trials), University Hospital of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J","family":"Kemper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asklepios Klinik Nord \u2013 Heidberg, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Konrad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital M\u00fcnster, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Luntz","sequence":"additional","affiliation":[{"name":"KKS (Coordination Center for Clinical Trials), University Hospital of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Querfeld","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital Berlin, University Hospital Berlin Charit\u00e9, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Sander","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Toenshoff","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, University Children\u2019s Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz T","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Children\u2019s Hospital K\u00f6ln, University Hospital K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"2025121409270025000_8.10.e024882.1","unstructured":"Lawrenz C , 2010. Inzidenzanalyse des nephrotischen Syndroms im Kindes- und Jugendalter in den Jahren 2005\u20132006. Inaugural-Dissertation. Rheinische Friedrich-Wilhelm-Universit\u00e4t Bonn http:\/\/hss.ulb.uni-bonn.de\/2010\/2170\/2170.pdf."},{"key":"2025121409270025000_8.10.e024882.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442096"},{"key":"2025121409270025000_8.10.e024882.3","first-page":"380","article-title":"Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"1","author":"Anon","year":"1988","journal-title":"Lancet"},{"key":"2025121409270025000_8.10.e024882.4","doi-asserted-by":"publisher","DOI":"10.1007\/BF01956754"},{"key":"2025121409270025000_8.10.e024882.5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005090922"},{"key":"2025121409270025000_8.10.e024882.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0794-1"},{"key":"2025121409270025000_8.10.e024882.7","doi-asserted-by":"crossref","unstructured":"Hahn D , Hodson EM , Willis NS , et al . Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2015:CD001533.doi:10.1002\/14651858.CD001533.pub5","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"2025121409270025000_8.10.e024882.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1559"},{"key":"2025121409270025000_8.10.e024882.9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00279.x"},{"key":"2025121409270025000_8.10.e024882.10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10157-010-0317-9","article-title":"Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome","volume":"14","author":"Nakamura","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"2025121409270025000_8.10.e024882.11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2008.06.003","article-title":"Clinical and laboratory assessment of cardiovascular risk in children: guidelines for screening, evaluation, and treatment","volume":"2","author":"Kwiterovich","year":"2008","journal-title":"J Clin Lipidol"},{"key":"2025121409270025000_8.10.e024882.12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.240"},{"key":"2025121409270025000_8.10.e024882.13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.260"},{"key":"2025121409270025000_8.10.e024882.14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070646"},{"key":"2025121409270025000_8.10.e024882.15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.354"},{"key":"2025121409270025000_8.10.e024882.16","first-page":"268","article-title":"Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center","volume":"72","author":"Fujinaga","year":"2009","journal-title":"Clin Nephrol"},{"key":"2025121409270025000_8.10.e024882.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.011"},{"key":"2025121409270025000_8.10.e024882.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-1877-x"},{"key":"2025121409270025000_8.10.e024882.19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00550206"},{"key":"2025121409270025000_8.10.e024882.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0899-6"},{"key":"2025121409270025000_8.10.e024882.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-011-2006-7"},{"key":"2025121409270025000_8.10.e024882.22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012121200"},{"key":"2025121409270025000_8.10.e024882.23","doi-asserted-by":"publisher","DOI":"10.1177\/1740774508091600"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-024882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:27:09Z","timestamp":1765733229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-024882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/bmjopen-2018-024882"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-024882","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}